
Consumer Staples · Soft Drinks & Non-alcoholic Beverages
$77.16
+0.12%
Vol: 2.3M
Friday, May 1, 2026
Monster Beverage stock around $77, recently down 2.75% over past month though up 6% over month and 31.23% over one year. 2025 net sales $8.29B (+10.7%), net income $1.91B (+26.3%) but faces valuation concerns. Rothschild & Co Redburn downgraded from Buy to Neutral April 29, reducing PT from $63 to $60. Goldman Sachs initiated Buy rating April 22. Analysts see 13.8% upside with average 12-month PT $84.55. Average rating Buy.
Monster Beverage will report Q1 2026 earnings on May 7, 2026, following strong Q4 2025 results announced earlier with net sales up 17.6% to $2.13 billion and diluted EPS up 64.9% to $0.46. The stock has experienced volatility, trading at $74.93 down 2.75% over the last month, though it remains up nearly 32% over the past 52 weeks. Bank of America and Stifel both lowered price targets recently (to $96 and $90 respectively) citing cost concerns from aluminum tariffs, but maintained Buy ratings. The mean analyst price target stands at $87.18 representing 12.9% upside.
Bank of America lowered Monster Beverage price target to $96 from $100 on April 10, 2026, citing valuation issues. Separately, Rothschild & Co Redburn downgraded the stock from Buy to Neutral on April 14, reducing its price target from $63 to $60. The company reported 2025 revenue of $8.29 billion, up 10.7% YoY, with earnings up 26.27%. Despite strong financial performance and analyst average rating of Buy with $79.63 price target, mixed insider selling sentiment and valuation pressures continue.
Monster reported record 2025 results with net sales up 10.7% to $8.29B and net income up 26.3% to $1.91B. Management flagged January 2026 sales up ~20.5% YoY but noted modest cost inflation from cans and tariffs. Bank of America and UBS cut price targets on valuation concerns (BofA to $96, UBS to $80). Despite near-term weakness, 16 analysts maintain Buy consensus with $80.19 average price target.
Monster Beverage experienced multiple analyst target reductions: UBS lowered to $80, RBC Capital and Wells Fargo also downgraded, Bank of America reduced to $96 maintaining Buy. Monster Energy and Strategic Brands segments grew 19% and 7.8% respectively with net profit of $449.2M. Stock at $76.19 with 63% 12-month gains.
Monster Beverage faces analyst headwinds with multiple April cuts to 2026 targets. Despite recent 6% 1-month pullback, stock shows strong 26.8% 1-year return. Q4 2025 results showed solid fundamentals: net sales $2.13B (+17.6%), full-year sales $8.29B (+10.7%), net income $1.91B (+26.3%). Core Monster Energy segment sales +18.9%.
Monster Beverage delivered double-digit net sales growth and margin expansion in 2025, though stock faces headwinds from elevated energy and aluminum prices. Energy drink category forecast to grow double-digit in 2026. Stock trading at $76.19 with consensus price target $74.64. Company launched Monster Energy Ultra Blue Hawaiian as new product. Tariff impact remains immaterial.
Monster Beverage reported record Q4 net sales of $2.13B (+17.6%) and full-year 2025 net sales of $8.29B (+10.7%), with strong international growth driving performance. However, the stock faced headwinds from analyst downgrades: Rothschild downgraded from Buy to Neutral with $60 PT, while UBS and Deutsche Bank lowered price targets. Goldman Sachs and RBC Capital maintained Buy ratings. The company faces valuation concerns relative to peers despite strong fundamentals and international expansion momentum.
UBS downgraded price target to $80 from $92 on April 6. NatWest Group acquired 193,395 shares. Stock faces valuation concerns versus peers despite record quarterly sales from international expansion. Insider selling raises confidence questions despite strong double-digit APAC and EMEA growth.
Monster Beverage reported strong 2025 results with net sales up 10.7% to $8.29B and net income up 26.3% to $1.91B. Q4 net sales reached $2.13B, up 17.6% YoY, with core Monster Energy segment sales up 18.9%. International revenue surged 26.9%, particularly from EMEA up 32.6%. Despite strong fundamentals, the stock has declined 10% over the past month amid valuation concerns versus peers like KDP. Analysts maintain consensus Moderate Buy with average price target of $83.76.
Monster Beverage reported strong Q4 2025 results with net sales rising 17.6% to $2.13B. Full-year 2025 net sales grew 10.7% to $8.29B with net income up 26.3% to $1.91B. Leadership reorganized effective February 25: Rob Gehring named CEO Americas, Guy Carling CEO EMEA & OSP, Emelie Tirre as Chief Strategy Officer. Stock surged to 52-week high of $87.38 post-earnings but declined 9% as management flagged aluminum tariffs and Midwest premium cost increases in early 2026. Currently trading mid-$70s with high volatility. Analyst sentiment moderate buy with 27 Buy, 11 Hold ratings. Consensus price target $91.33.
Monster Beverage delivered strong Q4 2025 results with net sales increasing 17.6% and 2025 full-year revenue reaching $8.29 billion (up 10.7% YoY). Monster Energy Drinks segment sales grew 17.5% on FX-adjusted basis. Net income was $449.2 million for the quarter. Analysts maintain bullish outlook with average Buy rating.
Monster Beverage reported record quarterly revenue with Q4 2025 net sales crossing $2 billion for the first time, increasing 17.6% to $2.13 billion from $1.81 billion year-ago. Full-year 2025 net sales rose 10.7% to $8.29 billion with net income increasing 26.3% to $1.91 billion and diluted EPS up 29.9% to $1.94. International operations, particularly in the EMEA region, were a key driver with a 32.6% fourth quarter lift. However, Deutsche Bank lowered Monster Beverage's price target to $90 from $94 on March 30, 2026, citing insider selling concerns and confidence issues. Recent analyst activity includes RBC Capital's Buy rating on March 23 and Goldman Sachs maintaining a Buy rating on March 22.
Monster Beverage reported strong 2025 full-year net sales growth of 10.7% to $8.29B with net income growth of 26.3%. Q4 net sales rose 17.6% with international sales growing 26.9%. Gross margin expanded to 55.8%. Deutsche Bank lowered PT to $90 from $94. Stock has declined 14.4% in the past month.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| KOCOCA | $78.69 | -0.10% | +2.0% | 22.7x | 0.36 | $338.9B |
| PEPPEPSICO | $157.61 | -0.56% | +1.1% | 17.3x | 0.41 | $216.6B |
| MNSTMONSTER | $77.16 | +0.12% | +3.9% | 30.4x | 0.51 | $75.4B |
| KDPKEURIG | $29.11 | -0.99% | +14.4% | 11.6x | 0.36 | $40.0B |
| WMTWALMART | $131.84 | -0.07% | +4.0% | 40.2x | 0.66 | $1.05T |
| COSTCOSTCO | $1,012.70 | -0.18% | -0.4% | 45.1x | 0.98 | $450.1B |
Price above both MAs — bullish structure.